SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-243057
Filing Date
2019-09-11
Accepted
2019-09-11 17:17:32
Documents
4
Effectiveness Date
2019-09-11

Document Format Files

Seq Description Document Type Size
1 S-8 d801842ds8.htm S-8 43292
2 EX-5.1 d801842dex51.htm EX-5.1 5047
3 EX-23.2 d801842dex232.htm EX-23.2 1446
4 GRAPHIC g801842dsp0009.jpg GRAPHIC 3104
  Complete submission text file 0001193125-19-243057.txt   55506
Mailing Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 415 CAMBRIDGE MA 02142 617-274-4000
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-233715 | Film No.: 191089023
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1